Enteric-coated aspirin

DRUG3 trials

Conditions

Atherosclerotic Cardiovascular DiseaseCarotid Artery StenosisCarotid AtherosclerosisCoronary Artery DiseaseIschemic Heart DiseaseIschemic StrokeMetastatic Triple Negative Breast CancerPeripheral Arterial Disease

Early Phase 1

Aspirin Resistance in Coronary Artery Disease

CompletedNCT00753935

Vanderbilt UniversityCoronary Artery Disease

Start: 2006-06-30End: 2014-03-31Updated: 2018-04-19

Phase 1

L-NMMA Plus Taxane Chemotherapy in Refractory Locally Advanced or Metastatic Triple Negative Breast Cancer Patients

CompletedNCT02834403

The Methodist Hospital Research InstituteMetastatic Triple Negative Breast Cancer

Start: 2016-11-30End: 2021-01-31Updated: 2023-12-15

Unknown Phase

Coated or Chewable Aspirin and a Hybrid Strategy to Mitigate Adverse Effects of Air Pollution in Stable Atherosclerotic Disease

RecruitingNCT06541691

Rajaie Cardiovascular Medical and Research CenterAtherosclerotic Cardiovascular Disease, Carotid Artery Stenosis, Carotid Atherosclerosis +4

Start: 2024-03-06End: 2027-03-30Target: 3000Updated: 2025-03-19

Related Papers

Abstract 3447: NOS inhibition reverses epithelial-to-mesenchymal transition and synergizes with alpelisib in metaplastic breast cancer

Cancer Research2023-04-04

Abstract P4-08-05: NOS inhibition reverses epithelial-to-mesenchymal transition and synergizes with alpelisib in metaplastic breast cancer

Cancer Research2023-03-01

Abstract CT037: Clinical phase Ib trial of L-NMMA plus docetaxel in the treatment of refractory locally advanced or metastatic triple negative breast cancer patients

Cancer Research2017-07-013 citations